Parkside Financial Bank & Trust’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.03K | Buy |
780
+557
| +250% | +$6.45K | ﹤0.01% | 1507 |
|
2025
Q1 | $1.95K | Buy |
223
+45
| +25% | +$393 | ﹤0.01% | 1893 |
|
2024
Q4 | $2.56K | Sell |
178
-183
| -51% | -$2.63K | ﹤0.01% | 1585 |
|
2024
Q3 | $8.15K | Sell |
361
-68
| -16% | -$1.54K | ﹤0.01% | 1311 |
|
2024
Q2 | $8.35K | Buy |
429
+269
| +168% | +$5.23K | ﹤0.01% | 1234 |
|
2024
Q1 | $6.01K | Hold |
160
| – | – | ﹤0.01% | 1294 |
|
2023
Q4 | $8.96K | Buy |
160
+43
| +37% | +$2.41K | ﹤0.01% | 1168 |
|
2023
Q3 | $4.83K | Buy |
117
+9
| +8% | +$371 | ﹤0.01% | 1386 |
|
2023
Q2 | $6.03K | Hold |
108
| – | – | ﹤0.01% | 1291 |
|
2023
Q1 | $6.03K | Hold |
108
| – | – | ﹤0.01% | 1290 |
|
2022
Q4 | $3.94K | Buy |
108
+20
| +23% | +$729 | ﹤0.01% | 1417 |
|
2022
Q3 | $3K | Buy |
88
+70
| +389% | +$2.39K | ﹤0.01% | 1462 |
|
2022
Q2 | $1K | Sell |
18
-34
| -65% | -$1.89K | ﹤0.01% | 1771 |
|
2022
Q1 | $4K | Buy |
52
+50
| +2,500% | +$3.85K | ﹤0.01% | 1424 |
|
2021
Q4 | $0 | Sell |
2
-8
| -80% | – | ﹤0.01% | 1921 |
|
2021
Q3 | $1K | Buy |
10
+4
| +67% | +$400 | ﹤0.01% | 1714 |
|
2021
Q2 | $1K | Buy |
6
+3
| +100% | +$500 | ﹤0.01% | 1674 |
|
2021
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 1648 |
|
2020
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1680 |
|